Universal Health Realty Income Trust (UHT) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
17 Jun, 2026Executive summary
Net income for Q1 2025 was $4.8 million, down from $5.3 million in Q1 2024, primarily due to lower property income and higher interest expense.
Net income attributable to shareholders rose to $316.7 million ($4.80 per diluted share) in Q1 2025, up from $261.8 million ($3.82 per diluted share) in Q1 2024.
Revenues decreased 2.4% year-over-year to $24.5 million, mainly from reduced occupancy at several medical office buildings.
Net revenues increased 6.7% year-over-year to $4.10 billion.
Funds from operations (FFO) fell to $11.9 million ($0.86 per diluted share) from $12.4 million ($0.90 per diluted share) in Q1 2024.
Financial highlights
Lease revenue from UHS facilities was $8.3 million; non-related parties contributed $14.3 million.
Interest income on financing leases was $1.4 million.
Operating income increased to $454.8 million from $388.8 million year-over-year.
Cash flow from operations was $360 million, down from $396 million, mainly due to delayed Medicaid payments.
Dividends paid were $10.2 million ($0.735/share), up from $10.0 million ($0.725/share) in Q1 2024.
Outlook and guidance
Management expects to fund capital expenditures and dividends through operating cash flow, available credit, and potential equity/debt issuance.
Sufficient capital resources are available for the next twelve months, but access to capital markets is subject to conditions.
Management highlighted risks from changes in government reimbursement, interest rates, and litigation.
Medicaid payment program delays and regulatory changes could materially impact future results.
Latest events from Universal Health Realty Income Trust
- Trustee elections, executive pay, and auditor ratification all passed with no shareholder questions.UHT
AGM 202622 Jun 2026 - Trustees, executive pay, and auditor were approved by shareholders in a virtual meeting.UHT
AGM 202522 Jun 2026 - All proposals, including trustee elections and auditor ratification, were approved by shareholders.UHT
AGM 202421 Jun 2026 - Q2 and H1 2024 net income and FFO rose, with higher dividends and ongoing industry risks.UHT
Q2 202417 Jun 2026 - Net income, revenues, and FFO rose, with higher interest costs and expanded credit capacity.UHT
Q3 202417 Jun 2026 - Net income and FFO rose year-over-year, supported by property income and prudent capital actions.UHT
Q4 202417 Jun 2026 - Raised 2025 guidance after strong Q2 results and incremental Medicaid reimbursements.UHT
Q2 202517 Jun 2026 - Net income and FFO dipped, with new development underway and higher borrowing costs noted.UHT
Q4 202517 Jun 2026 - Net income and FFO rose, credit capacity expanded, and new medical office construction began.UHT
Q1 202617 Jun 2026